Back
Rapt Therapeutics, Inc. 10K Form
Sell
40
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.42
Seasonality Move:
11.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RAPT News And Ratings
See the #1 stock for the next 7 days that we like better than RAPT
RAPT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-12.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.02 |
| Price / Book: | 3.75 |
Profitability
| EPS (TTM): | -10.51070 |
|---|---|
| Net Income (TTM): | $-105.6M |
| Gross Margin: | $-3.5M |
| Return on Equity: | -67.79% |
| Return on Assets: | -59.99% |
Rapt Therapeutics, Inc. Earnings Forecast
Key Rapt Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 0 years.
Rapt Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RAPT |
| CUSIP: | 75382E |
| Website: | rapt.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 12.04 |
| Quick Ratio: | 11.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RAPT Technical Analysis vs Fundamental Analysis
Sell
40
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy or a Sell?
-
Rapt Therapeutics, Inc. stock is rated a SellThe current Rapt Therapeutics, Inc. [RAPT] share price is $34.47. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.